Skip to main content
SpringerLink
Log in

HRT: transdermal safer than oral route with regard to stroke risk

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Renoux C, Dell’Aniello S, Garbe E, Suissa S.Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study. BMJ 340: [7 pages], 2010. Available from: URL: http://dx.doi.org/10.1136/bmj.c2519

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

HRT: transdermal safer than oral route with regard to stroke risk. React. Wkly. 1306, 4 (2010). https://doi.org/10.2165/00128415-201013060-00009

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201013060-00009

Keywords

Search

Navigation